Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells

Targeted therapy based on natural compounds is one of the best approaches against non-small cell lung cancer. Ursolic acid (UA), a pentacyclic triterpenoid derived from medicinal herbs, has anticancer activity. Studies on the molecular mechanism underlying UA’s anticancer activity are ongoing. Here,...

Full description

Bibliographic Details
Main Authors: Dong Young Kang, Nipin Sp, Jin-Moo Lee, Kyoung-Jin Jang
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/3/297
_version_ 1797541437217177600
author Dong Young Kang
Nipin Sp
Jin-Moo Lee
Kyoung-Jin Jang
author_facet Dong Young Kang
Nipin Sp
Jin-Moo Lee
Kyoung-Jin Jang
author_sort Dong Young Kang
collection DOAJ
description Targeted therapy based on natural compounds is one of the best approaches against non-small cell lung cancer. Ursolic acid (UA), a pentacyclic triterpenoid derived from medicinal herbs, has anticancer activity. Studies on the molecular mechanism underlying UA’s anticancer activity are ongoing. Here, we demonstrated UA’s anticancer activity and the underlying signaling mechanisms. We used Western blotting and real-time quantitative polymerase chain reaction for molecular signaling analysis. We also used in vitro angiogenesis, wound healing, and invasion assays to study UA’s anticancer activity. In addition, we used tumorsphere formation and chromatin immunoprecipitation assays for binding studies. The results showed that UA inhibited the proliferation of A549 and H460 cells in a concentration-dependent manner. UA exerted anticancer effects by inducing G0/G1 cell cycle arrest and apoptosis. It also inhibited tumor angiogenesis, migration, invasion, and tumorsphere formation. The molecular mechanism underlying UA activity involves UA’s binding to epidermal growth factor receptor (EGFR), reducing the level of phospho-EGFR, and thus inhibiting the downstream JAK2/STAT3 pathway. Furthermore, UA reduced the expressions of vascular endothelial growth factor (VEGF), metalloproteinases (MMPs) and programmed death ligand-1 (PD-L1), as well as the formation of STAT3/MMP2 and STAT3/PD-L1 complexes. Altogether, UA exhibits anticancer activities by inhibiting MMP2 and PD-L1 expression through EGFR/JAK2/STAT3 signaling.
first_indexed 2024-03-10T13:16:00Z
format Article
id doaj.art-f877b7560b8445f8b19feb42bc80b6f4
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T13:16:00Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-f877b7560b8445f8b19feb42bc80b6f42023-11-21T10:25:26ZengMDPI AGBiomedicines2227-90592021-03-019329710.3390/biomedicines9030297Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer CellsDong Young Kang0Nipin Sp1Jin-Moo Lee2Kyoung-Jin Jang3Department of Pathology, School of Medicine, Institute of Biomedical Science and Technology, Konkuk University, Chungju 27478, KoreaDepartment of Pathology, School of Medicine, Institute of Biomedical Science and Technology, Konkuk University, Chungju 27478, KoreaPharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Osong Health Technology Administration Complex, Cheongju-si 28159, KoreaDepartment of Pathology, School of Medicine, Institute of Biomedical Science and Technology, Konkuk University, Chungju 27478, KoreaTargeted therapy based on natural compounds is one of the best approaches against non-small cell lung cancer. Ursolic acid (UA), a pentacyclic triterpenoid derived from medicinal herbs, has anticancer activity. Studies on the molecular mechanism underlying UA’s anticancer activity are ongoing. Here, we demonstrated UA’s anticancer activity and the underlying signaling mechanisms. We used Western blotting and real-time quantitative polymerase chain reaction for molecular signaling analysis. We also used in vitro angiogenesis, wound healing, and invasion assays to study UA’s anticancer activity. In addition, we used tumorsphere formation and chromatin immunoprecipitation assays for binding studies. The results showed that UA inhibited the proliferation of A549 and H460 cells in a concentration-dependent manner. UA exerted anticancer effects by inducing G0/G1 cell cycle arrest and apoptosis. It also inhibited tumor angiogenesis, migration, invasion, and tumorsphere formation. The molecular mechanism underlying UA activity involves UA’s binding to epidermal growth factor receptor (EGFR), reducing the level of phospho-EGFR, and thus inhibiting the downstream JAK2/STAT3 pathway. Furthermore, UA reduced the expressions of vascular endothelial growth factor (VEGF), metalloproteinases (MMPs) and programmed death ligand-1 (PD-L1), as well as the formation of STAT3/MMP2 and STAT3/PD-L1 complexes. Altogether, UA exhibits anticancer activities by inhibiting MMP2 and PD-L1 expression through EGFR/JAK2/STAT3 signaling.https://www.mdpi.com/2227-9059/9/3/297ursolic acidNSCLCtumorsphereEGFRSTAT3MMP2
spellingShingle Dong Young Kang
Nipin Sp
Jin-Moo Lee
Kyoung-Jin Jang
Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
Biomedicines
ursolic acid
NSCLC
tumorsphere
EGFR
STAT3
MMP2
title Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
title_full Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
title_fullStr Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
title_full_unstemmed Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
title_short Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
title_sort antitumor effects of ursolic acid through mediating the inhibition of stat3 pd l1 signaling in non small cell lung cancer cells
topic ursolic acid
NSCLC
tumorsphere
EGFR
STAT3
MMP2
url https://www.mdpi.com/2227-9059/9/3/297
work_keys_str_mv AT dongyoungkang antitumoreffectsofursolicacidthroughmediatingtheinhibitionofstat3pdl1signalinginnonsmallcelllungcancercells
AT nipinsp antitumoreffectsofursolicacidthroughmediatingtheinhibitionofstat3pdl1signalinginnonsmallcelllungcancercells
AT jinmoolee antitumoreffectsofursolicacidthroughmediatingtheinhibitionofstat3pdl1signalinginnonsmallcelllungcancercells
AT kyoungjinjang antitumoreffectsofursolicacidthroughmediatingtheinhibitionofstat3pdl1signalinginnonsmallcelllungcancercells